Persistent URL of this record https://hdl.handle.net/1887/19737
Documents
-
- Download
- Front cover
-
open access
-
- Download
- Title page_Table of contents
-
open access
-
- Download
- Chapter 1 General introduction
-
open access
-
- Download
- Chapter 3
-
open access
- Full text at publishers site
-
- Download
- Chapter 4
-
open access
- Full text at publishers site
-
- Download
- Chapter 5
-
open access
- Full text at publishers site
-
- Download
- Chapter 6
-
open access
- Full text at publishers site
-
- Download
- Summary and general discussion
-
open access
-
- Download
- Summary and general discussion in Dutch
-
open access
-
- Download
- Afterword_Acknowledgements
-
open access
-
- Download
- List of publications
-
open access
-
- Download
- Back cover
-
open access
-
- Download
- Propositions
-
open access
In Collections
This item can be found in the following collections:
Genetic prognostic factors in uveal melanoma
- All authors
- Maat, W.
- Supervisor
- Luyten, G.P.M.
- Co-supervisor
- Velden, P.A. van der,; Jager, M.J.
- Qualification
- Doctor (dr.)
- Awarding Institution
- Leiden University Medical Center (LUMC) , Leiden University
- Date
- 2012-09-04
- ISBN (print)
- 9789053355633
Funding
- Sponsorship
- Dutch Cancer Society (KWF), Alcon, Allergan, AMO Netherlands BV, Bausch + Lomb, Laméris Ootech BV, Leids Oogheelkundig Ondersteunings Fonds, Medical Workshop, Merck Sharp & Dohme BV, Novartis Pharma BV, Oculenti Contactlenspraktijken, PamGene International BV, Pfizer BV, Rotterdamse Stichting Blindenbelangen, Stichting Blinden-Penning, Stichting Dondersfonds, Stichting Oogheelkunde Rijswijk, Thea Pharma